NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Quantitative MRI for Myelofibrosis

NCT01973881

RecruitingN/A

Sponsor: University of Michigan Rogel Cancer Center

Conditions: Myelofibrosis

Interventions: T1 Weighted MRI (magnetic resonance imaging)

Countries: United States

This study is for the development and validation of functional magnetic resonance imaging (MRI) parameters as biomarkers for analyzing extent of disease and quantifying response to treatment in patients with myelofibrosis.

Eligibility overview

Sex: ALL

Age: 18 Years to 99 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. Male /female subjects over the age of 18
2. Diagnosis of primary myelofibrosis, post-polycythemia vera myelofibrosis, or post-essential thrombocythemia myelofibrosis.
3. No contraindications to MRI
4. Able to undergo MRI without anesthesia

   \-

Exclusion Criteria:

1. Patients with pacemakers or other implanted magnetic devices that may malfunction or move because of the strong magnetic field inside the MRI room and scanner.
2. Any prior adverse event associated with MRI that is not related to injection of contrast agents or other medicines.

   \-

Locations (1)

Ann Arbor, Michigan, United States